78 related articles for article (PubMed ID: 19238926)
1. [Diabetology].
Egli M; Ruiz J
Rev Med Suisse; 2009 Jan; 5(186):101-5. PubMed ID: 19238926
[TBL] [Abstract][Full Text] [Related]
2. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
Tkác I
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
[TBL] [Abstract][Full Text] [Related]
3. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
Weiss IA; Valiquette G; Schwarcz MD
Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
[TBL] [Abstract][Full Text] [Related]
4. Glycemic targets for patients with type 2 diabetes mellitus.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
[TBL] [Abstract][Full Text] [Related]
5. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
[No Abstract] [Full Text] [Related]
6. Does intensive glycemic control improve cardiovascular outcomes?
Pendergrass M
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
[No Abstract] [Full Text] [Related]
7. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.
Soo Yeon S; Nesto RW
Rev Cardiovasc Med; 2008; 9(1):1-4. PubMed ID: 18418304
[No Abstract] [Full Text] [Related]
8. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Bonds DE; Kurashige EM; Bergenstal R; Brillon D; Domanski M; Felicetta JV; Fonseca VA; Hall K; Hramiak I; Miller ME; Osei K; Simons-Morton DG;
Am J Cardiol; 2007 Jun; 99(12A):80i-89i. PubMed ID: 17599428
[TBL] [Abstract][Full Text] [Related]
9. Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Mancia G
Circulation; 2010 Aug; 122(8):847-9. PubMed ID: 20733113
[No Abstract] [Full Text] [Related]
10. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
Lund SS; Vaag AA
Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
[No Abstract] [Full Text] [Related]
11. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
Seufert J
Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
[No Abstract] [Full Text] [Related]
12. [How effectively should hyperglycemia be treated in a type 2 diabetes patient?].
Eriksson J
Duodecim; 2009; 125(13):1387-94. PubMed ID: 19678494
[TBL] [Abstract][Full Text] [Related]
13. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
Sherman FT
Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
[No Abstract] [Full Text] [Related]
14. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
15. Implications of new diabetes treatment trials: should current clinical practice be altered?
Kravetz JD; Federman DG
Postgrad Med; 2009 May; 121(3):67-72. PubMed ID: 19491542
[TBL] [Abstract][Full Text] [Related]
16. [What has changed in the therapeutic strategy for type 2 diabetes mellitus?].
Casado PP; Szymaniec J; Conthe P
Rev Clin Esp; 2010 Sep; 210 Suppl 1():18-25. PubMed ID: 21130912
[TBL] [Abstract][Full Text] [Related]
17. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
Garza H
Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
[TBL] [Abstract][Full Text] [Related]
18. Lessons for dialysis investigators from the Steno-2 Study.
McFarlane PA
J Nephrol; 2008; 21(1):6-13. PubMed ID: 18264929
[TBL] [Abstract][Full Text] [Related]
19. ["The lower, the better:" this was not confirmed in the risk/benefit report of the ACCORD trial].
Scheen AJ
Rev Med Suisse; 2011 Aug; 7(306):1603-4. PubMed ID: 21972725
[No Abstract] [Full Text] [Related]
20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
